Bill Boudreaux is a distinguished pharmaceutical patent attorney with decades of experience spanning both in-house counsel roles and private practice. Known for his rare blend of strategic foresight and practical insight, Bill advises clients ranging from startups to Fortune Global 500 pharmaceutical and biotechnology companies on protecting and maximizing the value of their innovations. His counsel is informed by deep institutional knowledge gained through serving as lead patent counsel for several blockbuster drugs at Eli Lilly and Pfizer.
Clients turn to Bill for his sharp judgment and clarity when navigating complex patent portfolio management, life-cycle planning, and Hatch-Waxman litigation strategy. He is particularly adept at guiding companies through freedom-to-operate and validity analyses, IP due diligence, and global patent portfolio development. His approach reflects both legal precision and commercial awareness — qualities that consistently earn the trust of both legal departments and executive leadership.
Credentials
Education
- Louisiana State University, B.S., 1987
- Louisiana State University Paul M. Hebert Law Center, J.D., 1991
Bar Admissions
- Indiana
- Michigan
- Ohio
- U.S. Patent and Trademark Office
Court Admissions
- U.S. Court of Appeals for the Federal Circuit
- U.S. Supreme Court

